Results 291 to 300 of about 91,799 (300)

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

European Heart Journal, 2013
exaly  

Design, synthesis, SAR and molecular docking of novel green niacin-triketone HPPD inhibitor

Industrial Crops and Products, 2019
Ying Fu, Shuang Gao, Fei Ye
exaly  

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Journal of the American Medical Association (JAMA), 1987
D. Blankenhorn, S. Nessim, R. Johnson, M. Sanmarco, S. Azen, L. Cashin-Hemphill   +5 more
semanticscholar   +1 more source

Niacin

2005
openaire   +2 more sources

Niacin

2007
openaire   +1 more source

Niacin

2017
Gerald F. Combs, James P. McClung
openaire   +1 more source

Niacin

Reactions Weekly, 2013
openaire   +2 more sources

NIACIN

1954
openaire   +1 more source

Niacin

1989
openaire   +1 more source

Niacin

2006
openaire   +1 more source